SCHEMBL20174351

SCHEMBL20174351

c1ccc(-c2cc(-c3cccc4c3-c3ccccc3C43c4ccccc4-c4oc5ccccc5c43)nc3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 7/20 0.37
HPGD P15428 5/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPK1 P28482 2/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
EGFR P00533 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ACHE P22303 1/20 0.32
ELANE P08246 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174297 0.86 ACACA (0.42) ACACAHPGDKDM4EALDH1A1TDP1
SCHEMBL20174437 0.86 ACACA (0.38) ACACAHPGDKDM4EALDH1A1TDP1
SCHEMBL20174230 0.85 ALDH1A1 (0.38) HPGDKDM4EALDH1A1TDP1MAPK1
SCHEMBL20174258 0.85 KMT2A (0.36) HPGDKDM4EALDH1A1TDP1MAPK1
SCHEMBL20174339 0.85 ACACA (0.39) ACACAHPGDKDM4EALDH1A1TDP1
SCHEMBL20174227 0.84 KMT2A (0.36) ACACAHPGDKDM4EALDH1A1MAPK1
SCHEMBL18455628 0.84 ACACA (0.45) ACACAHPGDKDM4EALDH1A1TDP1
SCHEMBL20174301 0.83 ACACA (0.38) ACACAHPGDKDM4EALDH1A1TDP1
SCHEMBL20174337 0.83 ALDH1A1 (0.33) HPGDKDM4EALDH1A1MAPTL3MBTL1
SCHEMBL20174241 0.83 KMT2A (0.36) ACACAHPGDKDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG ACACA 2815/4885HPGD 2229/4885KDM4E 3633/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG ACACA 2815/4885HPGD 2229/4885KDM4E 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.